Nessan Bermingham
Chief Executive Officer, Intellia Therapeutics.
Companies
- Korro Bio, Inc.Board member Nov 7, 2023 to now1
- F-star Therapeutics, Inc.Board member Nov 24, 2020 to Mar 9, 20232
- Intellia TherapeuticsBoard member May 5, 2016 to Dec 14, 20173
- Intellia TherapeuticsChief executive officer May 5, 2016 to Dec 14, 20173
- Intellia TherapeuticsPresident May 5, 2016 to Dec 14, 20173
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Korro Bio, Inc. KRRO35,114 shares4$326.9K at $9.31Nov 3, 2023
- F-star Therapeutics, Inc.0 shares5Mar 8, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Nov 3, 2023Granted 35,114 shares of Korro Bio, Inc.4
- Mar 8, 2023Returned to company 6,328 shares at $7.12 of F-star Therapeutics, Inc.5
- Mar 8, 2023U 97,547 shares at $7.12 of F-star Therapeutics, Inc.5
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARKorro Bio, Inc., Board member
- 2
- 3SEC EDGARIntellia Therapeutics, Board member
- 4
- 5